Effect of hepatitis C positivity on survival in adult patients undergoing heart transplantation (from the United Network for Organ Sharing Database)

American Journal of Cardiology

Volumn 118, Issue 1, 2016, Pages 132-137

  Kumar, Sachin ^a   Deo, Salil V ^b   Altarabsheh, Salah E ^c   Dunlay, Shannon M ^d   Sarabu, Nagaraju ^b   Sareyyupoglu, Basar ^b   Elgudin, Yakov ^b   Medalion, Benjamin ^b   Elamm, Chantal ^b   Ginwalla, Mahazarin ^b   Zacharias, Michael ^b   Benatti, Rodolpho ^b   Oliveira, Guilherme H ^b   Kilic, Ahmet ^e   Fonarow, Gregg C ^f   Park, Soon J ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c King Hussein Medical Center Queen Alia Heart institute   (Jordan)

^d MAYO CLINIC   (United States)

^e THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATININE; HEPATITIS B ANTIGEN; INOTROPIC AGENT;

ACUTE GRAFT REJECTION; ADULT; AGE; ASSISTED CIRCULATION; BILIRUBIN BLOOD LEVEL; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEALTH INSURANCE; HEART TRANSPLANTATION; HEPATITIS B; HEPATITIS C; HUMAN; INTRAAORTIC BALLOON PUMP; KIDNEY FAILURE; LEFT VENTRICULAR ASSIST DEVICE; LIVER DYSFUNCTION; LIVER FAILURE; LONG TERM SURVIVAL; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEMBRANE OXYGENATOR; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL RATE; TREATMENT OUTCOME; COMPLICATION; GRAFT SURVIVAL; HEART FAILURE; MIDDLE AGED; MORTALITY; REGISTER; UNITED STATES; VIROLOGY;

ADULT; FEMALE; GRAFT SURVIVAL; HEART FAILURE; HEART TRANSPLANTATION; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84966746474     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2016.04.023     Document Type: Conference Paper

References (17)

1. J.M. Wilder, and A.J. Muir Strategies for treating chronic HCV infection in patients with cirrhosis: latest evidence and clinical outcomes Ther Adv Chronic Dis 6 2015 314 327
2. S. Lingala, and M.G. Ghany Natural history of hepatitis C Gastroenterol Clin North Am 44 2015 717 734
3. J. LaFleur, R. Hoop, E. Korner, S. DuVall, T. Morgan, P. Pandya, J. Han, K. Knippenberg, and R.E. Nelson Predictors of early discontinuation of pegylated interferon for reasons other than lack of efficacy in United States veterans with chronic hepatitis C Gastroenterol Nurs 38 2015 417 428
4. W. Zhao, F. Ji, S. Yu, Z. Li, and H. Deng Dilated cardiomyopathy and hypothyroidism associated with pegylated interferon and ribavirin treatment for chronic hepatitis C: case report and literature review Braz J Infect Dis 18 2014 110 113
5. G.L. Armstrong, A. Wasley, E.P. Simard, G.M. McQuillan, W.L. Kuhnert, and M.J. Alter The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 Ann Intern Med 144 2006 705 714
6. M.H. Lin, N.K. Chou, N.H. Chi, Y.S. Chen, H.Y. Yu, S.C. Huang, W.J. Ko, H.W. Chou, and S.S. Wang The outcome of heart transplantation in hepatitis C-positive recipients Transplant Proc 44 2012 890 893
7. M.R. Mehra, J. Kobashigawa, R. Starling, S. Russell, P.A. Uber, J. Parameshwar, P. Mohacsi, S. Augustine, K. Aaronson, and M. Barr Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006 J Heart Lung Transplant 25 2006 1024 1042
8. C. Legendre, V. Garrigue, C. Le Bihan, M.F. Mamzer-Bruneel, M.L. Chaix, P. Landais, H. Kreis, and S. Pol Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients Transplantation 65 1998 667 670
9. E.J. Gane, B.C. Portmann, N.V. Naoumov, H.M. Smith, J.A. Underhill, P.T. Donaldson, G. Maertens, and R. Williams Long-term outcome of hepatitis C infection after liver transplantation N Engl J Med 334 1996 815 820
10. B.J. Pereira, S.N. Natov, B.A. Bouthot, B.V. Murthy, R. Ruthazer, C.H. Schmid, and A.S. Levey Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group Kidney Int 53 1998 1374 1381
11. E. Righi, A. Londero, A. Carnelutti, U. Baccarani, and M. Bassetti Impact of new treatment options for hepatitis C virus infection in liver transplantation World J Gastroenterol 21 2015 10760 10775
12. I. Lee, R. Localio, C.M. Brensinger, E.A. Blumberg, E. Lautenbach, L. Gasink, V.K. Amorosa, and V. Lo Re 3rd Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivity J Heart Lung Transplant 30 2011 1266 1274
13. F.L. Luan, D.E. Schaubel, H. Zhang, X. Jia, S.J. Pelletier, F.K. Port, J.C. Magee, and R.S. Sung Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C Transplantation 85 2008 1601 1606
14. S. Trakroo, and K. Qureshi Successful treatment of chronic hepatitis C infection with direct-acting antivirals in a heart transplant recipient: a case report Transplant Proc 47 2015 2295 2297
15. B.A. Aqel, and H.E. Vargas Hepatitis C virus infection in nonliver solid organ transplant candidates and recipients Curr Opin Organ Transpl 20 2015 259 266
16. V. Saxena, F.M. Koraishy, M.E. Sise, J.K. Lim, M. Schmidt, R.T. Chung, A. Liapakis, D.R. Nelson, M.W. Fried, N.A. Terrault, and T. Hcv Safety and efficacy of sofosbuvir-containing regimens in hepatitis C infected patients with impaired renal function [e-pub ahead of print] Liver Int 2016 10.1111/liv.13102
17. H. Fontaine, A. Lazarus, S. Pol, C. Pecriaux, F. Bagate, P. Sultanik, E. Boueyre, M. Corouge, V. Mallet, A. Vallet-Pichard, P. Sogni, D. Duboc, H. Cochin, and G. Cardiology Bradyarrhythmias associated with sofosbuvir treatment N Engl J Med 373 2015 1886 1888